Notice of Republication
This article was republished on on January 8, 2026 to remove confidential information. Please download this article again to view the correct version.
Reference
- 1. Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IDL, Sorni P, et al. Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLoS One. 2025;20(9):e0323167. pmid:40982450
Citation: Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IDL, Sorni P, et al. (2026) Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLoS One 21(1): e0341486. https://doi.org/10.1371/journal.pone.0341486
Published: January 20, 2026
Copyright: © 2026 Sequera-Arquelladas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.